Literature DB >> 27826003

Poly(lactic acid)-based particulate systems are promising tools for immune modulation.

Carina Peres1, Ana I Matos2, João Conniot3, Vanessa Sainz3, Eva Zupančič2, Joana M Silva4, Luís Graça5, Rogério Sá Gaspar2, Véronique Préat6, Helena F Florindo7.   

Abstract

Poly(lactic acid) (PLA) is one of the most successful and versatile polymers explored for controlled delivery of bioactive molecules. Its attractive properties of biodegradability and biocompatibility in vivo have contributed in a meaningful way to the approval of different products by the FDA and EMA for a wide range of biomedical and pharmaceutical applications, in the past two decades. This polymer has been widely used for the preparation of particles as delivery systems of several therapeutic molecules, including vaccines. These PLA vaccine carriers have shown to induce a sustained and targeted release of different bacterial, viral and tumor-associated antigens and adjuvants in vivo, triggering distinct immune responses. The present review intends to highlight and discuss the major advantages of PLA as a promising polymer for the development of potent vaccine delivery systems against pathogens and cancer. It aims to provide a critical discussion based on preclinical data to better understand the major effect of PLA-based carrier properties on their interaction with immune cells and thus their role in the modulation of host immunity. STATEMENT OF SIGNIFICANCE: During the last decades, vaccination has had a great impact on global health with the control of many severe diseases. Polymeric nanosystems have emerged as promising strategies to stabilize vaccine antigens, promoting their controlled release to phagocytic cells, thus avoiding the need for multiple administrations. One of the most promising polymers are the aliphatic polyesters, which include the poly(lactic acid). This is a highly versatile biodegradable and biocompatible polymer. Products containing this polymer have already been approved for all food and some biomedical applications. Despite all favorable characteristics presented above, PLA has been less intensively discussed than other polymers, such as its copolymer PLGA, including regarding its application in vaccination and particularly in tumor immunotherapy. The present review discusses the major advantages of poly(lactic acid) for the development of potent vaccine delivery systems, providing a critical view on the main properties that determine their effect on the modulation of immune cells.
Copyright © 2016 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adjuvant; Immune modulation; Microparticles; Nanoparticles; Poly(lactic acid); Vaccine

Mesh:

Substances:

Year:  2016        PMID: 27826003     DOI: 10.1016/j.actbio.2016.11.012

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  17 in total

1.  Design of biodegradable nanoparticles to modulate phenotypes of antigen-presenting cells for antigen-specific treatment of autoimmune disease.

Authors:  Eiji Saito; Robert Kuo; Kevin R Kramer; Nishant Gohel; David A Giles; Bethany B Moore; Stephen D Miller; Lonnie D Shea
Journal:  Biomaterials       Date:  2019-08-17       Impact factor: 12.479

2.  Harnessing the versatility of PLGA nanoparticles for targeted Cre-mediated recombination.

Authors:  Ngoc B Nguyen; Cheng-Han Chen; Yulong Zhang; Peng Zhao; Benjamin M Wu; Reza Ardehali
Journal:  Nanomedicine       Date:  2019-04-23       Impact factor: 5.307

3.  Designing drug-free biodegradable nanoparticles to modulate inflammatory monocytes and neutrophils for ameliorating inflammation.

Authors:  Eiji Saito; Robert Kuo; Ryan M Pearson; Nishant Gohel; Brandon Cheung; Nicholas J C King; Stephen D Miller; Lonnie D Shea
Journal:  J Control Release       Date:  2019-02-27       Impact factor: 9.776

Review 4.  Emerging biomaterial-based strategies for personalized therapeutic in situ cancer vaccines.

Authors:  Dixita Ishani Viswanath; Hsuan-Chen Liu; David P Huston; Corrine Ying Xuan Chua; Alessandro Grattoni
Journal:  Biomaterials       Date:  2021-11-30       Impact factor: 12.479

5.  Therapeutic vaccination against leukaemia via the sustained release of co-encapsulated anti-PD-1 and a leukaemia-associated antigen.

Authors:  Xiaoling Xie; Yuxing Hu; Tong Ye; Yiran Chen; Lijuan Zhou; Feng Li; Xiaobo Xi; Shuang Wang; Yanjie He; Xiaoyong Gao; Wei Wei; Guanghui Ma; Yuhua Li
Journal:  Nat Biomed Eng       Date:  2020-10-12       Impact factor: 25.671

Review 6.  Future of human Chlamydia vaccine: potential of self-adjuvanting biodegradable nanoparticles as safe vaccine delivery vehicles.

Authors:  Rajnish Sahu; Richa Verma; Saurabh Dixit; Joseph U Igietseme; Carolyn M Black; Skyla Duncan; Shree R Singh; Vida A Dennis
Journal:  Expert Rev Vaccines       Date:  2018-02-06       Impact factor: 5.217

Review 7.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

Review 8.  Modulating the foreign body response of implants for diabetes treatment.

Authors:  Bhushan N Kharbikar; Gauree S Chendke; Tejal A Desai
Journal:  Adv Drug Deliv Rev       Date:  2021-01-21       Impact factor: 17.873

Review 9.  Nanomedicine Strategies to Target Tumor-Associated Macrophages.

Authors:  Karin Binnemars-Postma; Gert Storm; Jai Prakash
Journal:  Int J Mol Sci       Date:  2017-05-04       Impact factor: 5.923

10.  Toughened Poly(lactic acid)/BEP Composites with Good Biodegradability and Cytocompatibility.

Authors:  Qingguo Wang; Yongxuan Li; Xue Zhou; Tongyao Wang; Liyan Qiu; Yuanchun Gu; Jiabing Chang
Journal:  Polymers (Basel)       Date:  2019-08-28       Impact factor: 4.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.